Why the Bubs (ASX:BUB) share price surged 22% higher

This infant formula company started the month on a high…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Bubs Australia Ltd (ASX: BUB) share price was an incredibly strong performer on Tuesday.

The embattled infant formula company's shares jumped a massive 22% to 41 cents.

Despite this sizeable gain, the Bubs share price is still down a sizeable 62% over the last 12 months.

jump in asx share price represented by man jumping in the air in celebration

Image source: Getty Images

Why did the Bubs share price jump 22%?

Investors were bidding the Bubs share price higher on Tuesday following a promising development in China.

On Monday, the Chinese government announced that it will support couples who wish to have a third child. This compares to its previous policy which limited families to just two children.

The Chinese government revealed that it is making the move due to the country's ageing population, which continues to grow. According to Xinhua, China's population aged 60 or above accounted for 18.7% of its total population in 2020, 5.44 percentage points higher than in 2010.

The new policy is expected to help improve China's population structure, actively respond to the ageing population, and preserve the country's human resource advantages.

How does Bubs benefit?

As an infant formula manufacturer with a keen focus on the China market, the prospect of a quicker birth rate is a big positive for Bubs.

Especially given how there were concerns that the country's infant formula market would soon fall into a contraction due to its declining birth rate.

However, it is worth remembering that this doesn't guarantee that Bubs' sales will pick up. Competition in the lucrative market continues to increase and domestic brands are becoming increasingly popular with consumers ahead of Bubs and A2 Milk Company Ltd (ASX: A2M).

And while a2 Milk may have a marketing budget that allows it to compete, Bubs doesn't have that luxury and is already burning through bucket loads of cash each quarter.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended A2 Milk and BUBS AUST FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why Kingsgate, Neuren, Newcrest, and Pushpay shares are rising today

These ASX shares are avoiding the market selloff on Tuesday.

Read more »

A young woman wearing overalls and a yellow t-shirt kicks one leg in the air showing excitement over the latest ASX 200 shares to hit 52-week highs
Share Gainers

Why Neuren, Northern Star, Race Oncology, and Westgold shares are storming higher

These ASX shares are starting the week in a positive fashion.

Read more »

A woman wearing yellow smiles and drinks coffee while on laptop.
Share Gainers

Why APM, Macquarie Telecom, Northern Star, and Origin shares are rising today

These ASX shares are having a strong session despite the market selloff.

Read more »

Two boys with cardboard rockets strapped to their backs, indicating two ASX companies with rocketing share prices
Share Gainers

Catch these fast-rising 2 ASX shares before it's too late: Celeste

This pair of stocks rocketed up in February during reporting season, but are still great value for those willing to…

Read more »

three businessmen high five each other outside an office building with graphic images of graphs and metrics superimposed on the shot.
Share Gainers

Why Arafura, Myer, Volpara, and Xero shares are zooming higher

These ASX shares are making their shareholders smile on Thursday.

Read more »

medical asx share price represented by doctor giving thumbs up
Healthcare Shares

Guess which ASX biotech stock just rocketed 29% on big FDA news

The ASX healthcare share is attracting investor interest following FDA approval for its targeted cancer therapy compound.

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Share Gainers

Why Mesoblast, PolyNovo, Pushpay, and Weebit Nano shares are charging higher

These ASX shares are having a strong session despite the market selloff.

Read more »

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why InvoCare, Pentanet, Sayona Mining, and Weebit Nano shares are storming higher

These ASX shares are having a strong session on Tuesday.

Read more »